Public Transcriptomic Data Mining for SCLC: From Candidate Markers to Therapeutic Exploration

COLEC12 and MUC1 are novel diagnostic markers and therapeutic targets for SCLC, offering potential for targeted treatments and future research.

Authors

Institutions

Publication Details

Journal
Clinical & Translational Oncology
Published
2026-03-21
DOI
https://doi.org/10.1007/s12094-025-04158-8
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Public Transcriptomic Data Mining for SCLC: From Candidate Markers to Therapeutic Exploration

Fangyuan Qu, Bo Yan, Guangyao Zhou, Qiang Zhang et al.
Clinical & Translational Oncology
Lung Cancer Research Studies
article

Public Transcriptomic Data Mining for SCLC: From Candidate Markers to Therapeutic Exploration

Fangyuan Qu, Bo Yan, Guangyao Zhou, Qiang Zhang, Yuechen Cui, C. Li, Lianmin Zhang, Hailin Liu, Tingting Qin, Zhenfa Zhang
article en

Abstract

COLEC12 and MUC1 are novel diagnostic markers and therapeutic targets for SCLC, offering potential for targeted treatments and future research.

Clinical & Translational Oncology
Hebei Medical University (CN), Nankai University (CN), Tianjin Medical University Cancer Institute and Hospital (CN), First Affiliated Hospital of Hebei Medical University (CN)
Good health and well-being
Openalex Percentile: Top 13%
Lung Cancer Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.